BiotechTube
Stemmatters

Stemmatters

Guimarães, Portugal· Est.
stemmatters.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Stemmatters is a private, revenue-generating CDMO based in Guimarães, Portugal, offering end-to-end contract development and cGMP manufacturing solutions for regenerative medicine products. It operates as a one-stop shop, providing services in contract development, analytical testing, formulation development, and manufacturing for cell therapies, including iPSC-derived products and CAR-T cells. The company is actively engaged in collaborative R&D projects and partnerships, positioning itself as a key European player in the advanced therapy CDMO landscape.

Regenerative MedicineCell Therapy

Technology Platform

Integrated CDMO platform for cell therapy, specializing in process development, cGMP manufacturing, formulation development using advanced biomaterials, and analytical services for ATMPs.

Funding History

2
Total raised:$2.5M
Grant$700K
Seed$1.8M

Opportunities

The global cell and gene therapy market growth is creating a critical shortage of specialized GMP manufacturing capacity, presenting a major opportunity for specialized CDMOs like Stemmatters.
Its participation in EU-funded consortia and strategic partnerships in high-growth areas like iPSC technology positions it at the forefront of advanced therapy innovation and client acquisition.

Risk Factors

Revenue is dependent on the clinical success of client programs, leading to potential volatility.
The competitive landscape for CGT CDMOs is intensifying with larger, well-funded entrants.
Maintaining stringent regulatory compliance and continuously investing in evolving manufacturing technologies are constant operational and financial risks.

Competitive Landscape

Stemmatters competes in the specialized CGT CDMO space against global players like Lonza, Catalent, and Charles River, as well as other focused CDMOs such as Oxford Biomedica, Cell and Gene Therapy Catapult, and ElevateBio. Its differentiation lies in being a fully integrated, European-based specialist with a strong focus on collaboration and participation in cutting-edge consortia.

More companies in Regenerative Medicine →More companies in Portugal →